newsrelease

Trialing New Medical Products Gets Faster and More Secure

Longmont, Colorado, December 13, 2011

Data security and accuracy is vital to all industries, particularly in the health field. The process by which a pharmaceutical company compiles and analyzes information from clinical trials can significantly affect the timing and viability of a new product. nSpire Health is changing this process, by providing its domestic and international pharmaceutical customers with faster, more accurate, and more reliable information.

nSpire Health, a company which develops and manufactures respiratory care tools and services, has selected AT&T* to provide wireless connectivity for an nSpire Health mobile data services application that collects and analyzes information from patients and delivers it directly to pharmaceutical companies trialing a new product. nSpire Health utilizes a wireless device and AT&T’s Enterprise On-Demand platform – a custom web portal that helps control and manage wireless device inventory –  to capture data measuring a patient’s intake of and response to new respiratory products. This data is then sent to nSpire Health’s customers – pharmaceutical companies. The companies can use this information to evaluate the new product and help them support their case in advancing a new drug through the FDA’s approval processes.

Benefits to nSpire Health

As the healthcare industry moves toward electronic files for patients and companies, nSpire Health recognized increasing competition not only in price points, but also in accuracy and security of information.

  • Previously, nSpire Health had no single way of monitoring usage of its wireless device. Patients would take an nSpire Health device home for the purpose of trialing new medical products, but would then often misuse it. With AT&T EOD service, nSpire Health can monitor usage, restrict or disable certain features, as well as deliver the data compiled from patients.
  • This capability allows nSpire Health to conduct medical monitoring, with proper controls, at a managed cost.
  • With AT&T’s wireless network and EOD platform, nSpire Health is better positioned to provide its customers data integrity and offer a more efficient solution for capturing and transmitting that information.

"Patient trials of new drugs are a very important part of research and development processes for international pharmaceutical companies, as this helps them to create and market new drugs," said Chip Owen, Global Director of Clinical Trial Information Services for nSpire Health. "We knew we needed a cost-effective solution that moved as quickly as our customers do and maintained a high level of data accuracy and security – AT&T answered our call for flexibility in machine-to-machine services."

To view how nSpire Health is utilizing AT&T’s EOD platform, check out this video: http://www.youtube.com/watch?v=rM__wW9gM6Y.

News Sources